rs144527582

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2

The NM_000489.6(ATRX):​c.3641A>T​(p.Asn1214Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0000631 in 1,205,054 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 19 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N1214S) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00034 ( 0 hom., 9 hem., cov: 23)
Exomes 𝑓: 0.000035 ( 0 hom. 10 hem. )

Consequence

ATRX
NM_000489.6 missense

Scores

2
7
7

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3O:1

Conservation

PhyloP100: 4.35

Publications

3 publications found
Variant links:
Genes affected
ATRX (HGNC:886): (ATRX chromatin remodeler) The protein encoded by this gene contains an ATPase/helicase domain, and thus it belongs to the SWI/SNF family of chromatin remodeling proteins. This protein is found to undergo cell cycle-dependent phosphorylation, which regulates its nuclear matrix and chromatin association, and suggests its involvement in the gene regulation at interphase and chromosomal segregation in mitosis. Mutations in this gene are associated with X-linked syndromes exhibiting cognitive disabilities as well as alpha-thalassemia (ATRX) syndrome. These mutations have been shown to cause diverse changes in the pattern of DNA methylation, which may provide a link between chromatin remodeling, DNA methylation, and gene expression in developmental processes. Multiple alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2017]
ATRX Gene-Disease associations (from GenCC):
  • alpha thalassemia-X-linked intellectual disability syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • ATR-X-related syndrome
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • intellectual disability-hypotonic facies syndrome, X-linked, 1
    Inheritance: XL Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.06881654).
BP6
Variant X-77681615-T-A is Benign according to our data. Variant chrX-77681615-T-A is described in ClinVar as [Benign]. Clinvar id is 133652.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000341 (38/111516) while in subpopulation AFR AF = 0.00123 (38/30806). AF 95% confidence interval is 0.000924. There are 0 homozygotes in GnomAd4. There are 9 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 9 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATRXNM_000489.6 linkc.3641A>T p.Asn1214Ile missense_variant Exon 9 of 35 ENST00000373344.11 NP_000480.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATRXENST00000373344.11 linkc.3641A>T p.Asn1214Ile missense_variant Exon 9 of 35 1 NM_000489.6 ENSP00000362441.4 P46100-1

Frequencies

GnomAD3 genomes
AF:
0.000341
AC:
38
AN:
111459
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00124
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000141
AC:
25
AN:
177478
AF XY:
0.0000955
show subpopulations
Gnomad AFR exome
AF:
0.00169
Gnomad AMR exome
AF:
0.000114
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000347
AC:
38
AN:
1093538
Hom.:
0
Cov.:
31
AF XY:
0.0000278
AC XY:
10
AN XY:
359660
show subpopulations
African (AFR)
AF:
0.00126
AC:
33
AN:
26142
American (AMR)
AF:
0.000145
AC:
5
AN:
34504
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19193
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30127
South Asian (SAS)
AF:
0.00
AC:
0
AN:
52757
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40420
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4096
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
840393
Other (OTH)
AF:
0.00
AC:
0
AN:
45906
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000341
AC:
38
AN:
111516
Hom.:
0
Cov.:
23
AF XY:
0.000267
AC XY:
9
AN XY:
33746
show subpopulations
African (AFR)
AF:
0.00123
AC:
38
AN:
30806
American (AMR)
AF:
0.00
AC:
0
AN:
10493
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2639
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3563
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2640
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6028
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
217
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
52923
Other (OTH)
AF:
0.00
AC:
0
AN:
1526
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.000374
ESP6500AA
AF:
0.00156
AC:
6
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000132
AC:
16

ClinVar

Significance: Benign
Submissions summary: Benign:3Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Oct 25, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 09, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Alpha thalassemia-X-linked intellectual disability syndrome Benign:1
Jun 22, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Other:1
Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.14
T
BayesDel_noAF
Uncertain
0.0
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Benign
0.14
.;.;T;T
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.92
D;.;D;D
M_CAP
Pathogenic
0.86
D
MetaRNN
Benign
0.069
T;T;T;T
MetaSVM
Uncertain
0.69
D
PhyloP100
4.4
PrimateAI
Benign
0.47
T
PROVEAN
Uncertain
-3.0
D;D;.;.
REVEL
Uncertain
0.58
Sift
Pathogenic
0.0
D;D;.;.
Sift4G
Benign
0.19
T;T;T;D
Polyphen
0.90
P;.;.;.
Vest4
0.33
MVP
0.83
MPC
0.090
ClinPred
0.13
T
GERP RS
5.7
gMVP
0.18
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs144527582; hg19: chrX-76937107; COSMIC: COSV99055414; API